Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 501-505

  Long III, Harry J ^a   Nelimark, Robert A ^b   Podratz, Karl C ^a   Suman, Vera ^a   Keeney, Gary L ^a   Nikcevich, Daniel A ^c   Kugler, John W ^d   Rowland Jr , Kendrith M ^e   Kardinal, Carl G ^f   Wos, Edward J ^g  

^a MAYO CLINIC   (United States)

^b Sioux Community Cancer Consortium   (United States)

^c Duluth CCOP   (United States)

^d Illinois Oncol Res Assoc CCOP   (United States)

^e Carle Cancer Center CCOP   (United States)

^f Ochsner CCOP   (United States)

^g SANFORD RESEARCH   (United States)

Author keywords

Combination chemotherapy; Endometrial cancer

Indexed keywords

CISPLATIN; DOXORUBICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FEVER; EDEMA; FEMALE; HOT FLUSH; HUMAN; LETHARGY; LEUKOPENIA; METASTASIS; NAUSEA AND VOMITING; NEPHROTOXICITY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; SURVIVAL RATE; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; VINBLASTINE;

EID: 32644455468     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.08.021     Document Type: Article

References (12)

1. American Cancer Society Cancer facts and figures 2005 2005 American Cancer Society Atlanta
2. P. Sabbatini, C. Aghajanian, and D. Spriggs Chemotherapy in gynecologic cancer Curr. Opin. Oncol. 10 1998 429 433
3. T.E. Davis Hormonal therapy of endometrial cancer D.P. Rose Endocrinology of cancer vol. 1 1979 CRC Press Boca Raton, FL 117 134
4. J.T. Thigpen, J.A. Blessing, H. Homesley, W.T. Creasman, and G. Sutton Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Gynecol. Oncol. 33 1989 68 70
5. H.J. Long, D.M. Pfeifle, H.S. Wieand, J.E. Krook, J.H. Edmonson, and J.C. Buckner Phase II evaluation of carboplatin in advanced endometrial carcinoma J. Natl. Cancer Inst. 80 1988 276 278
6. J.T. Thigpen, H.J. Buchsbaum, C. Mangan, and J.A. Blessing Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Cancer Treat Rep. 63 1979 21 27
7. H.G. Ball, J.A. Blessing, S.S. Lentz, and D.G. Mutch A Phase II trial of taxol in advanced and recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol. Oncol. 56 1995 120 [abstract]
8. T.W. Burke, and D.M. Gershenson Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma Clin. Obstet. Gynecol. 39 3 1996 716 727
9. J.T. Thigpen, M.F. Brady, H.D. Homesley, J. Malfetano, B. DuBeshter, and R.A. Burger Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a Gynecologic Oncology Group study J. Clin. Oncol. 22 2004 3902 3908
10. H.J. Long III, R.M. Langdon Jr., S.S. Cha, M.H. Veeder, D.M. Pfeifle, and J.E. Krook Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinoma Gynecol. Oncol. 58 1995 240 243
11. G.F. Fleming, V.L. Brunetto, D. Cella, K.Y. Look, G.C. Reid, and A.R. Munkarah Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group study J. Clin. Oncol. 22 2004 2159 2166
12. P.J. Hoskins, K.D. Swenerton, J.A. Pike, F. Wong, P. Lim, and C. Acquino-Parsons Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a Phase II study J. Clin. Oncol. 19 2001 4048 4053